Identification of new potent inhibitors of dengue virus NS3 protease from traditional Chinese medicine database

Warning The system is temporarily closed to updates for reporting purpose.

Dwivedi, Vivek Dhar and Tripathi, Indra Prasad P. and Bharadwaj, Shiv Kumar and Kaushik, Aman Chandra and Mishra, Sarad Kumar (2016) Identification of new potent inhibitors of dengue virus NS3 protease from traditional Chinese medicine database. VirusDisease, 27 (3). pp. 220-225. ISSN 2347-3584 (Print) 2347-3517 (Online)

[thumbnail of Identification_of_new_potent_inhibitors_of_dengue_virus_NS3_protease_from_traditional_Chinese_medicine_database.pdf] PDF
Restricted to Registered users only

Download (821kB) | Request a copy


Dengue virus (DENV) has emerged as an increasing fitness problem in the world for which no specialized drug is available. The non-structural protein NS3 protease of DENV has already been recognized as a potential therapeutic target for the discovery and development of novel antiviral agents against DENV infections. In this study, we employed the virtual screening technique to explore the potent inhibitors of DENV NS2B/NS3pro from Traditional Chinese Medicine (TCM) database. Total 200 inhibitors from TCM against DENV NS3pro were screened and only five TCM compounds like eriodictyol 7-O-glucuronide, luteolin 8-C-beta-glucopyranoside, (-)-epicatechin-3-O-gallate, 6-O-trans-p-coumaroylgeniposide and luteolin-7-O-glucoside were selected for further analysis which showed binding energies, −7.000, −7.380, −7.380, −7.440 and −7.440 kcal/mol, respectively. The findings of this study suggest that these five TCM compounds can be considered as potent inhibitors for DENV NS2B/NS3pro for the development of anti-dengue drugs.
Item Type: Article
Uncontrolled Keywords: Dengue; Drug discovery; Inhibitors; NS2B/NS3; TCM
Divisions: Sabancı University Nanotechnology Research and Application Center
Faculty of Engineering and Natural Sciences
Depositing User: Shiv Kumar Bharadwaj
Date Deposited: 21 Aug 2017 15:25
Last Modified: 22 May 2019 13:51

Actions (login required)

View Item
View Item